Literature DB >> 30093595

Opioid prescribing decreases after learning of a patient's fatal overdose.

Jason N Doctor1, Andy Nguyen2, Roneet Lev3, Jonathan Lucas4, Tara Knight2, Henu Zhao2, Michael Menchine5.   

Abstract

Most opioid prescription deaths occur among people with common conditions for which prescribing risks outweigh benefits. General psychological insights offer an explanation: People may judge risk to be low without available personal experiences, may be less careful than expected when not observed, and may falter without an injunction from authority. To test these hypotheses, we conducted a randomized trial of 861 clinicians prescribing to 170 persons who subsequently suffered fatal overdoses. Clinicians in the intervention group received notification of their patients' deaths and a safe prescribing injunction from their county's medical examiner, whereas physicians in the control group did not. Milligram morphine equivalents in prescriptions filled by patients of letter recipients versus controls decreased by 9.7% (95% confidence interval: 6.2 to 13.2%; P < 0.001) over 3 months after intervention. We also observed both fewer opioid initiates and fewer high-dose opioid prescriptions by letter recipients.
Copyright © 2018, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30093595     DOI: 10.1126/science.aat4595

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

Review 1.  Opioid Prescribing in an Opioid Crisis: What Basic Skills Should an Oncologist Have Regarding Opioid Therapy?

Authors:  Joseph Arthur; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2019-04-01

2.  Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations.

Authors:  Rosanna Smart; Rosalie Liccardo Pacula
Journal:  Am J Drug Alcohol Abuse       Date:  2019-10-11       Impact factor: 3.829

3.  Same-Day vs Different-Day Elective Upper and Lower Endoscopic Procedures by Setting.

Authors:  Peiqi Wang; Susan M Hutfless; Eun J Shin; Christian Hartman; Sarah Disney; Christopher C Fain; Kathy P Bull-Henry; Daniel K Daniels; Tsion Abdi; Vikesh K Singh; Anthony N Kalloo; Martin A Makary
Journal:  JAMA Intern Med       Date:  2019-07-01       Impact factor: 21.873

4.  The protocol of the Application of Economics & Social psychology to improve Opioid Prescribing Safety trial 2 (AESOPS-2): Availability of opioid harm.

Authors:  Marcella A Kelley; Stephen D Persell; Jeffrey A Linder; Mark W Friedberg; Daniella Meeker; Craig R Fox; Noah J Goldstein; Tara K Knight; Dina Zein; Mark D Sullivan; Jason N Doctor
Journal:  Contemp Clin Trials       Date:  2021-12-08       Impact factor: 2.226

5.  Changes in Cancer Screening Rates Following a New Cancer Diagnosis in a Primary Care Patient Panel.

Authors:  Annabel Z Wang; Michael L Barnett; Jessica L Cohen
Journal:  JAMA Netw Open       Date:  2022-07-01

6.  The protocol of the Application of Economics & Social psychology to improve Opioid Prescribing Safety Trial 1 (AESOPS-1): Electronic health record nudges.

Authors:  Marcella A Kelley; Stephen D Persell; Jeffrey A Linder; Mark W Friedberg; Daniella Meeker; Craig R Fox; Noah J Goldstein; Tara K Knight; Dina Zein; Theresa A Rowe; Mark D Sullivan; Jason N Doctor
Journal:  Contemp Clin Trials       Date:  2021-02-24       Impact factor: 2.226

7.  Antibiotic-Associated Adverse Events in Hospitalized Children.

Authors:  Rebecca G Same; Alice J Hsu; Sara E Cosgrove; Eili Y Klein; Joe Amoah; Adam L Hersh; Matthew P Kronman; Pranita D Tamma
Journal:  J Pediatric Infect Dis Soc       Date:  2021-05-28       Impact factor: 3.164

8.  Evaluation of Clinical Decision Support to Reduce Sedative-Hypnotic Prescribing in Older Adults.

Authors:  Natasha N Joglekar; Yatindra Patel; Michelle S Keller
Journal:  Appl Clin Inform       Date:  2021-06-09       Impact factor: 2.762

9.  Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data.

Authors:  Mike Vuolo; Brian C Kelly
Journal:  Am J Psychiatry       Date:  2021-12-08       Impact factor: 19.242

Review 10.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.